These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 15730423)
1. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment. Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514 [TBL] [Abstract][Full Text] [Related]
3. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425 [TBL] [Abstract][Full Text] [Related]
4. Follow-up of differentiated thyroid carcinoma. Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026 [TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation. Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522 [TBL] [Abstract][Full Text] [Related]
6. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery. Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345 [TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882 [TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642 [TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation]. Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893 [TBL] [Abstract][Full Text] [Related]
14. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course]. Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307 [TBL] [Abstract][Full Text] [Related]
15. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study. Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265 [TBL] [Abstract][Full Text] [Related]
16. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy. Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976 [TBL] [Abstract][Full Text] [Related]
17. Treatment for microcarcinoma of the thyroid--clinical experience. Küçük NO; Tari P; Tokmak E; Aras G Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573 [TBL] [Abstract][Full Text] [Related]
18. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930 [TBL] [Abstract][Full Text] [Related]
19. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence]. Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]